Vincent K Lam

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Cancer research communications

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Jessica J Lin, Justin F Gainor, Vincent K Lam, Christine M Lovly
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease. Cancer discovery 14 (6) (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Joseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James Robert White, Noushin Niknafs, Lamia Rhymee, Gavin Pereira, Nisha Rao, Benny Weksler, Nathan Bahary, Jillian A Phallen, Alessandro Leal, David L Bartlett, Kristen A Marrone, Jarushka Naidoo, Akul Goel, Benjamin Levy, Samuel Rosner, Christine L Hann, Susan C Scott, Josephine Feliciano, Vincent K Lam, David S Ettinger, Qing Kay Li, Peter B Illei, Kim Monkhorst, Robert B Scharpf, Julie R Brahmer, Victor E Velculescu, Blair A Jobe, Patrick M Forde, Valsamo Anagnostou
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Geoffrey Liu, Vincent K Lam
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis. Advances in therapy (2023)
Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, Mehmet Altan, Don L Gibbons, Frank V Fossella, Vincent K Lam, Anisha B Patel, Marcelo Vailati Negrão, Xiuning Li, Frank E Mott, Jianjun Zhang, Lei Feng, George Blumenschein, Anne S Tsao, John Victor Heymach
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)